Market Blog Technical Analysis

Nice Bullish Chart But A Pullback Would Be Nice (NASDAQ:BLUE)

bluebird bio Inc (NASDAQ:BLUE) broke out to a new 52-week high yesterday, accompanied by a good volume suggesting higher levels. This biotech stock has been in a nice uptrend for the last seven months and technically looks very strong with both 50-day and 200-day exponential moving averages going up, while %K line is on top of %D line and MACD rising. BLUE is now on the overbought level, so this
Market Blog

Positive sentiments for Bluebird Bio and VMWare

BLUE – Bluebird Bio Inc is focused on developing and commercializing drugs based on gene therapy to treat patients with genetic diseases and cancer. BLUE – Bluebird Bio Inc Fundamentals Previously closed at 47.72 Day's high 51.46 Day's low 47.61 P/E ratio NA EPS -2.44   Analysts opinion Bluebird Bio announced that its ongoing phase 2 study evaluating the product candidate “Lenti-D” for the treatment of cerebral adrenoleukodystrophy (CALD) will
Market Blog

Bluebird Bio and Under Armour may see a positive sentiment in the long run

UA – Under Armour, Inc - last closed at $69.96 – Bullish (Long term) Under Armour, a sportswear giant’s stocks fell about 11% yesterday, with the news of Morgan Stanley Downgrading the stock to “Sell”. Jay Sole, an analyst at Morgan Stanley, cut its stock price target for UA from $103 to $62. According to Jay Sole, the UA has changed its pricing, and marketing strategy. “UA has always competed